Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma

NCT02595242 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Prednisone

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.